United Kingdom· GB-APID-37481811000001107
Dovato 50mg/300mg tablets
A lamivudine and dolutegravir product containing dolutegravir + lamivudine, registered in United Kingdom by ViiV Healthcare UK Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lamivudine and dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR25 (lamivudine and dolutegravir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Lamivudine and dolutegravir · ATC J05AR25
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dolutegravir + Lamivudine
- Manufacturer
- ViiV Healthcare UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AR25
- ATC class
- Lamivudine and dolutegravir
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 4
- gtin05054290002300
- gtin05054290006759
- gtin05054290006742
- gtin5000123115150
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine and dolutegravir in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOVATOViiV Healthcare BV, Amersfoort
- FinlandDovatoViiV Healthcare BV
- SwitzerlandDovato
- SpainDOVATO 50 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULAViiv Healthcare B.V.
- NetherlandsDovato 50 mg/300 mg filmomhulde tablettenViiV healthcare B.V.
- NorwayDovatoViiV Healthcare BV (1)
- PolandDovatoViiV Healthcare BV
- SwedenDOVATO 50 mg/300 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Dovato
- Liechtenstein · Dovato
- Norway · Dovato
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/78601cff-0c07-4bd5-bebb-961e6ffd17bc GET /v1/drugs/78601cff-0c07-4bd5-bebb-961e6ffd17bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37481811000001107",
"desc": "Dovato 50mg/300mg tablets (ViiV Healthcare UK Ltd)",
"form": "Oral tablet",
"vpid": "37531111000001103",
"source": "dmd",
"vtm_id": "787164001",
"strength": "50 mg",
"substance": "Dolutegravir + Lamivudine",
"ingredient": "Dolutegravir sodium",
"supplier_code": "16436711000001101"
}See everything about lamivudine and dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.